Does a two-step screening strategy using FIB-4 index and genetic variants predict liver-related events in patients with MASLD?
A two-step screening strategy using the FIB-4 index and genetic variants can efficiently identify MASLD patients at high risk for liver-related events.
The approach of measuring the FIB-4 index first followed by assessment of genetic polymorphisms efficiently detected patients at high risk of developing LRE. Therefore, this two-step strategy could be used as a screening method in large populations of patients with MASLD.
Seko et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: